Anvisa resumes dissemination of medical device price monitoring data

News Healthcare & Pharma General Updates

Date: 10th Mar, 2025 Source: National Health Surveillance Agency (Anvisa) Country: Brazil Original Source

Brief

On March 10, 2025, the National Health Surveillance Agency (Anvisa) issued an update regarding Anvisa resumes dissemination of medical device price monitoring data. The agency has resumed publishing price monitoring data for medical devices on its Business Intelligence (BI) platform, following a temporary suspension to review and improve the process. This move aims to enhance transparency and provide valuable information for regulatory and sectorial analyses, reiterating Anvisa's commitment to providing clear and accessible information to society.

This content is restricted.

Highlights content goes here...

This content is restricted.

National Health Surveillance Agency (Anvisa)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Anvisa resumes dissemination of medical device price monitoring data

Brief

National Health Surveillance Agency (Anvisa)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Anvisa resumes dissemination of medical device price monitoring data

Brief

National Health Surveillance Agency (Anvisa)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.